[HTML] sciencedirect.comFull View

[HTML][HTML] Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: systematic review and …

E Valeriani, E Porreca, JI Weitz, S Schulman… - Journal of Thrombosis …, 2020 - Elsevier
Abstract Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …
被引用次数：17 相关文章

[引用][C] Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and …

E Valeriani, E Porreca, M Candeloro, JI Weitz… - Journal of Thrombosis …, 2020 - elibrary.ru

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz, S Schulman… - JOURNAL OF …, 2020 - ricerca.unich.it
Background: Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …
[HTML] jthjournal.org

[HTML][HTML] Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and …

E Valeriani, E Porreca, JI Weitz, S Schulman… - Journal of Thrombosis …, 2020 - jthjournal.org
Abstract Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz… - Journal of …, 2020 - researchinformation.amsterdamumc …
Background: Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz… - … of Thrombosis and …, 2020 - europepmc.org
Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz… - … of Thrombosis and …, 2020 - Wiley Online Library
Abstract Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz, S Schulman… - JOURNAL OF …, 2020 - iris.uniroma1.it
Background: Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …

Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta …

E Valeriani, E Porreca, JI Weitz… - … of thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) are recommended over vitamin K
antagonists (VKAs) for the treatment of venous thromboembolism (VTE). Concomitant …